Adults scheduled for full-body skin exams between May and August 2022 were recruited (Figure 1) and given a Sklip mobile dermatoscope, valued at US $99.99. They were instructed to image 1-3 lesions of concern using both smartphones and dermatoscopes. A teledermatologist reviewed all images for diagnosis, management, quality, and clinical utility. Clinical utility was defined as images that increased the teledermatologist’s confidence in diagnosis and management. A dermatologist different from the teledermatologist evaluated the same lesions in-office.

The degree of agreement was assessed using the percentage of agreement and Cohen κ (95% CI). Cohen κ values were interpreted using the scale developed by Landis and Koch [5]. Excel (Microsoft Corporation) was used for data collection and analysis.

This study was approved by the institutional review board (IRB) of the UCSF Human Research Protection Program and SFVAMC Research and Development Committee, IRB study number 21-33538. Participants provided informed consent with the option to opt out of the study. Participants were not compensated, and their data was anonymized and stored in a password-protected file.

Substantial agreement was found between the teledermatologists and in-office dermatologists, consistent with previous studies [2,6]. However, the wide CIs indicate the need for further studies with larger sample sizes and implementation improvements, especially for identifying life-threatening malignancies. We recommend providing patients’ medical history to teledermatologists. In one discordant case, a history of vitiligo could have differentiated from postinflammatory hypopigmentation. A recent study developed a checklist for mobile teledermoscopy image quality [7], which could be shared with patients to improve image quality. Because the teledermatologist had a lower threshold for biopsies, a follow-up office visit should be pursued when a procedure is recommended.

Given the high proportion of benign neoplasms in our study, teledermoscopy implementation for patient-identified lesions could lead to an increased burden for telediagnosis services. To increase the malignancy detection, we recommend providing patient education on high-risk features, such as the ABCDEs (asymmetry, border, color, diameter, and evolving) of melanoma or the 7-point checklist, before imaging [8].

This study is limited by its single-center design, small study population, and voluntary participation. The nonresponse rate to the initial invitation was 89% (n=399), which may be due to mail delivery issues, lack of interest, or time constraints. While premalignant lesions were identified, no malignant lesions were imaged. Future studies that involve larger cohorts, different health care settings, and more teledermatologists could elicit additional information on the efficacy of direct-to-patient mobile teledermoscopy.

Substantial agreement was found between direct-to-patient mobile teledermoscopy and in-office evaluation in the diagnoses and management of patient-identified lesions. Most participants reported ease with mobile teledermoscopy use; however, most lesions were benign, indicating the need for patient education on high-risk features to ensure appropriate lesions are imaged. Providing direct-to-patient mobile teledermoscopy services may expand the reach of existing teledermatology practice.